Abstract:The concepts of transcriptional intratumor heterogeneity and phenotypic plasticity have gained significant attention in relation to the development of tumor resistance to cancer treatments [1]. In several cancer types, recent studies have linked certain somatic genomic aberrations to the presence of specific transcriptional states in malignant cells [2,3]. However, our general understanding of drivers of epigenetic and transcriptional plasticity stays somewhat fragmented. In theory, this gap could be filled through the generation and analysis of single-cell multi-omics datasets of human tumors coupled with clinical information. In practice, such datasets are pretty scarce, and existing data certainly do not allow for a global analysis of the genetic drivers of cell plasticity and heterogeneity across cancer types. On the other hand, the scientific community has already generated rich bulk transcriptomics datasets coupled with genetic and clinical information (e.g., TCGA) that could be used to answer the question about the relationship between genetic and epigenetic landscapes if proportions of cells in different malignant states could be extracted via a computational deconvolution of the transcriptomic signal. Unfortunately, available methods for accurate bulk data deconvolution require reference single-cell transcriptomics datasets, which limits the applicability of such approaches to study large pan-cancer datasets. We provide a solution to this problem by creating and benchmarking an algorithmic approach that allows extracting the transcriptional heterogeneity information from bulk tumor profiles without the need for a single-cell reference when a matched DNA-sequencing experiment is available. The latter is true for thousands of tumor samples, including all TCGA datasets. We present results of a pan-cancer analysis linking genetic aberrations with proportions of malignant cells in specific transcriptional states that shed light on the potential genetic drivers underlying malignant cell heterogeneity. References 1. Boeva, V. et al. Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries. Nat. Genet. 49, 1408–1413 (2017). 2. Neftel, C. et al. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma. Cell 178, 835-849.e21 (2019). 3. Moorman, A. R. et al. Progressive plasticity during colorectal cancer metastasis. BioRxiv Prepr. Serv. Biol. 2023.08.18.553925 (2023) doi:10.1101/2023.08.18.553925. Citation Format: Agnieszka Kraft, Josephine Yates, Florian Barkmann, Valentina Boeva. Unraveling potential genetic drivers of intratumor transcriptional heterogeneity and phenotypic plasticity in malignant cells [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Translating Cancer Evolution and Data Science: The Next Frontier; 2023 Dec 3-6; Boston, Massachusetts. Philadelphia (PA): AACR; Cancer Res 2024;84(3 Suppl_2) nr IA024.

Epigenetic regulation during cancer transitions across 11 tumour types

Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers

The chromatin accessibility landscape of primary human cancers

Uncovering dark matter in cancer by identifying epigenetic drivers

An Integrative Pan-Cancer-wide Analysis of Epigenetic Enzymes Reveals Universal Patterns of Epigenomic Deregulation in Cancer

A single-cell map of dynamic chromatin landscapes of immune cells in renal cell carcinoma

Integrative pan cancer analysis reveals epigenomic variation in cancer type and cell specific chromatin domains

Genetic and Epigenetic Dysregulation of Transcriptional Enhancers in Cancer

Cancer epigenomics: DNA methylomes and histone-modification maps

Defining the Regulatory Logic of Breast Cancer Using Single-Cell Epigenetic and Transcriptome Profiling

Transcriptional Landscape of Human Cancers

The Epigenetic Hallmarks of Cancer

Unveiling epigenetic regulatory elements associated with breast cancer development

Abstract IA024: Unraveling potential genetic drivers of intratumor transcriptional heterogeneity and phenotypic plasticity in malignant cells

Histone Mutations and Cancer

Comprehensive multimodal and multiomic profiling reveals epigenetic and transcriptional reprogramming in lung tumors

Epigenetic mechanisms underlying the dynamic expression of cancer-testis genes, PAGE2, -2B and SPANX-B, during mesenchymal-to-epithelial transition

Epigenetic contribution to cancer

Single cell atlas reveals multilayered metabolic heterogeneity across tumour types

Epigenomic heterogeneity as a source of tumour evolution

Single-cell multi-modal chromatin profiles revealing epigenetic regulations of cells in hepatocellular carcinoma